ENDOCRINE CONSULT / PEER REVIEWED

Part 2: Controlling BP in Diabetes Patients

Author and Disclosure Information

 

References

Monitor the patient’s BP at every visit, and advise the patient to regularly measure his or her BP at home with a BP cuff. Patients who may need assistance with at-home monitoring can be directed to an online guide on how to accurately measure their BP (see www.heart.org/en/health-topics/high-blood-pressure/understanding-blood-pressure-readings/monitoring-your-blood-pressure-at-home). For those who report consistently above-goal measurements at home, advise them to check their BP cuff, because an ill-fitting cuff is a well-known cause of inaccurate measurement. Patients also should be assessed for medication nonadherence, white coat hypertension, and secondary hypertension.7,8 If a patient’s BP is truly above goal, a step-up in therapy may be appropriate because without adequate BP control, the benefit in mortality and morbidity may not be fully realized.28

In Part 3, we’ll check in with Mr. W and discuss which patients require assessment for dyslipidemia. We’ll also explore the treatments, such as statin therapy, for this condition.

Pages

Recommended Reading

Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR
Clinician Reviews
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Clinician Reviews
Lyumjev ultra-rapid-acting insulin gets FDA nod  
Clinician Reviews
T2D plus heart failure packs a deadly punch
Clinician Reviews
ED visits for life-threatening conditions declined early in COVID-19 pandemic
Clinician Reviews
Normal-weight prediabetes patients also benefit from lifestyle intervention
Clinician Reviews
Diabetes control in U.S. youth has worsened over time
Clinician Reviews
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
Clinician Reviews
Part 1: Self-care for Diabetes Patients
Clinician Reviews
Cognitive deficits complex in youths with type 2 diabetes
Clinician Reviews